Jana Von Hehn
Chief Scientific Officer at Rett Syndrome Research Trust- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Mark Slama
Having worked with Jana from the perspective of a Phase 1 clinical site, it is very apparent that she has a solid understanding of the clinical research process with a thorough knowledge of the protocols, regulations, & SOPs. Her friendly, clear and precise communication was instrumental in conducting highly successful clinical trials. I look forward to having the opportunity to work with Jana again.
Kathy Spiegel
Jana is bright, energetic, and a delight to work with. Her experience at a small pharmaceutical company allowed her to become familiar and proficient in many areas of drug development: drug supply, clinical trial design, clinical monitoring, data review, regulatory reporting, to name just a few. She was never scared to learn something new, and she was extremely competent and responsible in everything she tackled. I think she would be a valuable asset for any company.
Mark Slama
Having worked with Jana from the perspective of a Phase 1 clinical site, it is very apparent that she has a solid understanding of the clinical research process with a thorough knowledge of the protocols, regulations, & SOPs. Her friendly, clear and precise communication was instrumental in conducting highly successful clinical trials. I look forward to having the opportunity to work with Jana again.
Kathy Spiegel
Jana is bright, energetic, and a delight to work with. Her experience at a small pharmaceutical company allowed her to become familiar and proficient in many areas of drug development: drug supply, clinical trial design, clinical monitoring, data review, regulatory reporting, to name just a few. She was never scared to learn something new, and she was extremely competent and responsible in everything she tackled. I think she would be a valuable asset for any company.
Mark Slama
Having worked with Jana from the perspective of a Phase 1 clinical site, it is very apparent that she has a solid understanding of the clinical research process with a thorough knowledge of the protocols, regulations, & SOPs. Her friendly, clear and precise communication was instrumental in conducting highly successful clinical trials. I look forward to having the opportunity to work with Jana again.
Kathy Spiegel
Jana is bright, energetic, and a delight to work with. Her experience at a small pharmaceutical company allowed her to become familiar and proficient in many areas of drug development: drug supply, clinical trial design, clinical monitoring, data review, regulatory reporting, to name just a few. She was never scared to learn something new, and she was extremely competent and responsible in everything she tackled. I think she would be a valuable asset for any company.
Mark Slama
Having worked with Jana from the perspective of a Phase 1 clinical site, it is very apparent that she has a solid understanding of the clinical research process with a thorough knowledge of the protocols, regulations, & SOPs. Her friendly, clear and precise communication was instrumental in conducting highly successful clinical trials. I look forward to having the opportunity to work with Jana again.
Kathy Spiegel
Jana is bright, energetic, and a delight to work with. Her experience at a small pharmaceutical company allowed her to become familiar and proficient in many areas of drug development: drug supply, clinical trial design, clinical monitoring, data review, regulatory reporting, to name just a few. She was never scared to learn something new, and she was extremely competent and responsible in everything she tackled. I think she would be a valuable asset for any company.
Experience
-
Rett Syndrome Research Trust
-
United States
-
Research Services
-
1 - 100 Employee
-
Chief Scientific Officer
-
Mar 2022 - Present
-
-
Sr. Director of Research & Clinical Strategy
-
May 2019 - Mar 2022
-
-
Director of Research
-
Jan 2018 - May 2019
-
-
-
Concert Pharmaceuticals, Inc.
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Associate Director, Clinical Development
-
Jan 2017 - Jan 2018
-
-
Sr. Clinical Development Scientist
-
Jan 2016 - Dec 2016
-
-
-
Karyopharm Therapeutics Inc.
-
United States
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Sr. Clinical Project Manager
-
Jun 2014 - Oct 2015
-
-
-
Sage Therapeutics
-
United States
-
Biotechnology Research
-
400 - 500 Employee
-
Sr. Mgr, Clinical Operations & Development
-
Nov 2013 - May 2014
-
-
Consultant, Clinical Operations
-
Aug 2013 - Nov 2013
-
-
-
-
Clinical Program Manager
-
Jan 2011 - Mar 2013
Oversight of phase II autism and fragile X programs
-
-
Clinical Research Scientist
-
Apr 2010 - Dec 2010
Clinical study management for Fragile X and Autism disorders and phase I.
-
-
-
-
Clinical Development Associate
-
Sep 2007 - Dec 2009
Manage phase I and II clinical trials, generate study-related documents, assist with data analysis & presentations, manage outsourced vendors, maintain SOPs Manage phase I and II clinical trials, generate study-related documents, assist with data analysis & presentations, manage outsourced vendors, maintain SOPs
-
-
-
Emory University
-
United States
-
Higher Education
-
700 & Above Employee
-
Graduate Student
-
Sep 2001 - Jun 2007
Research into human disease states including Galactosemia in the yeast model system and Ataxia-Telangiectasia in the yeast, mouse, and cell culture model systems. Demonstrated that mitochondrial dysfunction likely contributes to the unknown symptomology of A-T and that mitochondrial biology is a key target of cancer pathways. Research into human disease states including Galactosemia in the yeast model system and Ataxia-Telangiectasia in the yeast, mouse, and cell culture model systems. Demonstrated that mitochondrial dysfunction likely contributes to the unknown symptomology of A-T and that mitochondrial biology is a key target of cancer pathways.
-
-
Education
-
2001 - 2007
Emory University School of Medicine
PhD, Genetics & Molecular Biology -
1997 - 2001
University of Central Florida
B.S., Molecular Biology & Microbiology
Community
